The collaboration aims to turn scientific discoveries into practical healthcare solutions by combining MIT’s research expertise with Abu Dhabi’s expanding life sciences ecosystem.
The initiative brings together SK bioscience, global health nonprofit PATH, consulting firm Slalom and technology partner SK AX to create an evidence-based system that helps researchers evaluate vaccine candidates before they enter costly late-stage clinical trials.
The test detects the virus by identifying its genetic material in blood samples, allowing health workers to confirm infections quickly and accurately.
Researchers found that postmenopausal women taking hormone therapy while receiving tirzepatide lost approximately 35% more weight than women treated with tirzepatide alone.
Researchers can use the platform to design CRISPR screening experiments, analyse single-cell RNA sequencing data and generate three-dimensional protein structures, chemistry drawings and genome browser tracks.
Biogen has paused or discontinued funding for most of Apellis’ legacy research portfolio while conducting a comprehensive review of the acquired company’s clinical and preclinical assets.
Unlike CAR-T therapy, which requires patient-specific cell modification and lengthy manufacturing, this treatment is delivered as a ready-to-use infusion, making it more accessible in standard hospital settings.
During the congress, specialists from the Moscow-based center presented research on head and neck imaging, the use of AI-powered diagnostic algorithms, and strategies for improving the quality of medical imaging examinations.
The announcement follows growing calls from public health advocates and humanitarian organizations urging the US government to share available supplies of MBP134 to support outbreak control efforts in Central Africa.
The move marks an important step toward evaluating the technology for Good Manufacturing Practice (GMP)-compliant manufacturing while improving the efficiency of producing next-generation medicines.